“Fontem US LLC (Fontem US) today announces that it has submitted Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration (FDA) seeking authorization for the continued marketing of a wide range of its myblu electronic vaping products. The PMTA submissions include data from a comprehensive range of laboratory and clinical scientific studies, including product analyses, behavioral data, nonclinical health risk information, and information on the impact to both users and non-users of tobacco products”
BILL TARLING — You can expect Big Tobacco companies to very soon start pushing the narrative “we paid a fortune to submit our PMTA, so little companies should have to do it to or be pulled off the competition market — we know they can’t afford the PMTA submission costs.
ARTICLE LINK:
Fontem US LLC Submits Premarket Tobacco Applications for myblu Electronic Vaping Products
Store
